Drug Trial Radar · NCT04882085
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
Last checked: Nov 20, 2026Latest source record: Oct 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Aug 26, 2021
Primary completion
Aug 31, 2023
Study completion Aug 31, 2023
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- May 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, randomized, multi-center, interventional, active-controlled Phase 4 study to evaluate the efficacy and safety of CAZ-AVI versus BAT in the treatment of infected participants with selected infection types (Hospital Acquired Pneumonia \[HAP\] (including Ventilator-Associated Pneumonia \[VAP\]); Complicated Urinary-Tract Infection \[cUTI\]; Complicated Intra-Abdominal Infection \[cIAI\]; Bloodstream Infection \[BSI\]) due to carbapenem-resistant Gram-negative pathogens in China.This study will be an estimation study. The statistical inference will be based on point estimate and confidence interval.
Conditions
- Urinary Tract Infection
- Acute Pyelonephritis
- Hospital Acquired Pneumonia
- Ventilator-associated Pneumonia
- Bacteremia
- Intra-abdominal Infection
Interventions
Zavicefta, Ceftazidime-AvibactamDrug
CAZ-AVI 2.5 g (2 g ceftazidime + 0.5 g avibactam) administered IV as a 2 hour infusion every 8 hours. Dose adjustments are available for participants with CrCL ≤50 mL/min.
Best Available TreatmentDrug
main treatment expected to be used as either monotherapy or in combination are colistin, tigecycline, fosfomycin, amikacin, and meropenem
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Clinical Cure at Test of Cure (TOC) Visit - Microbiologically Modified Intent-to-Treat (mMITT) Analysis SetTime frame: At TOC visit (From Day 21 up to Day 24)
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
Jiangyin People's Hospital
Jiangyin, China
Shanghai Fifth People's Hospital, Fudan University
Shanghai, China
The First Affiliated Hospital of Bengbu Medical
Bengbu, Anhui, China
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Chizhou People's Hospital
Chizhou, Anhui, China
Fuyang People's Hospital
Fuyang, Anhui, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Zhongshan Hospital Xiamen University
Xiamen, Fujian, China
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
Qingyuan People's Hospital
Qingyuan, Guangdong, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
The Second People's Hospital of Shenzhen
Shenzhen, Guangdong, China
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
Affiliated Hospital of Guilin Medical College
Guilin, Guangxi, China
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China
Affiliated Hospital of Hebei University
Baoding, Hebei, China
Luoyang Central Hospital
Luoyang, Henan, China
NanYang central hospital
Nanyang, Henan, China
Henan provincial people's hospital
Zhengzhou, Henan, China
Henan provincial people's hospital
Zhengzhou, Henan, China
Baotou Central Hospital
Baotou, Inner Mongolia, China
Jiangyin People's Hospital
Jiangyin, Jiangsu, China
Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Subei People's Hospital of Jiangsu province
Yangzhou, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Chengdu Xinhua Hospital
Chengdu, Sichuan, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
The First People's Hospital of Kunming (South Hospital)
Kunming, Yunnan, China
The First people's Hospital of Kunming
Kunming, Yunnan, China
The First People's Hospital of Kunming Ganmei Hospital (North Hospital)
Kunming, Yunnan, China
Zhejiang Hospital
Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
Lishui People's Hospital
Lishui, Zhejiang, China
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
The 2nd Affiliated Hospital of WMU
Wenzhou, Zhejiang, China
Wenzhou Central Hospital
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.